U.S. health care trails peer nations

This article originally appeared here.
Analysis Describes Economic Anatomy of U.S. Health Care
Analysis Describes Economic Anatomy of U.S. Health Care

(HealthDay News) -- Despite the increases in resources devoted to health care in the United States, multiple health care metrics show that the United States is trailing peer nations, according to a special communication published in the Nov. 13 issue of the Journal of the American Medical Association, a theme issue on critical issues in U.S. health care.

Hamilton Moses III, M.D., from the Alerion Institute and Alerion Advisors LLC in North Garden, Va., and colleagues used publicly available data to identify trends in health care mainly from 1980 to 2011.

The authors note that U.S. health care employed 15.7 percent of the workforce in 2011, with expenditures of $2.7 trillion. Since 1970, yearly growth decreased but, at 3 percent per year, exceeded any industry and gross domestic product overall. Despite the increased resources, the United States is trailing peer nations in multiple health metrics, including life expectancy at birth and survival with many diseases. Since 2000, price, not demand for services or the aging population, caused 91 percent of the cost increases; personal out-of-pocket spending has decreased; and chronic illnesses account for 84 percent of costs in the entire population. The most change was due to consolidation, information technology, and perception of the patient as a consumer. These forces create tensions between the aims of patients, physicians, and payers.

"A national conversation, guided by the best data and information, aimed at explicit understanding of choices, trade-offs, and expectations, using broader definitions of health and value, is needed," Moses and colleagues conclude.

Several authors disclosed financial ties to the pharmaceutical and other industries.

Full Text
Editorial (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs